Chairperson, CS Pien

Mr. Pien has been the chairman of the Board of Directors since 2018.

Mr. Pien is the member of the Board of many Limited’s including Airoha Technology Corp., iDESYN Semiconductor Corp., SINONAR SOLAR CORP., Petroleum Resourcing (Hong Kong) Limited, Advanced Lithium Electrochemistry(KY)Co., Ltd., and the Supervisor in LinkWin Technology Co., Ltd. and  EirGenix Inc.. Besides, Mr. Pien had over 30 years investing experience.

He was expert in the field at chemical engineering, computer sciences and manufacturing system engineering during the school year.

Mr. Pien graduated with a Master of Materials Science and Engineering degree from Lehigh University in US.

CEO, Tina Huang, PhD

Tina joined Vivasolis in 2016 as Acting CEO.

Tina had over 24 years of experience in the life science and financial fields. Her experiences cover academic, operational and investment fields. In recent years, Tina had been involved in over 30 drug development programs starting from discovery to NDA stages. Tina had served senior positions at the Industrial Bank of Taiwan, WI Harper Group.

Tina received her Ph.D. in Molecular Biology and Biochemistry from The State University of New York and EMBA degree from China Europe International Business School.

Senior Vice President, Ming-Shiuan Wu, PhD

Dr. Wu Ming-Shiuan joined Vivasolis in 2016 as Senior Vice President. In this role, he is responsible for the research and development of Vivasolis’ innovative pipelines.

With a biomedical career spanning more than 20 year, he worked extensively in the healthcare area with a particular focus on pharmaceuticals, device and biomedicals.

Prior to Vivasolis, Ming-Shiuan was the Acting General Manager for Taiwan Bio Therapeutics, a biotech company focused on the clinical development of mesenchymal stem cell. Prior to that position, he led the research and development group at Purzer Pharmaceutical Co., Ltd. Earlier in his career, he held various leadership roles, including Director, Clinical Development at Perfect Health Biotechnology Co., Ltd.; Vice President, Research and Development at Chenho Pharmaceutical Co., Ltd.; and Project Manager, Oncology at TTY Biopharm Company Limited.

Ming-Shiuan holds a Ph. D. in Internal Medicine from The University of Tokyo.

Consultant, Professor Jaw-Wen Chen, MD

Dr. Chen is Professor of Institute of Pharmacology and Professor of Institute of Emergency and Critical Care Medicine, School of Medicine and Vice Direct of Cardiovascular Research Center at National Yang Ming University, and Direct of Department of Medical Research at Taipei Veterans General Hospital.

Dr. Chen is a specialist in Cardiology, Internal Medicine and is affiliated with Taipei Veterans General Hospital and was selected as Taiwan’s top 100 doctors by Business Weekly.

He received his medical degree from Kaohsiung Medical College and had spent the previous year as postdoctoral research fellow at Harvard University. He has been in practice for more than 30 years.

Operation consultant, Li-Ming Shen, PhD

Consultant, Ting-Ting Chang, PhD

Dr. Chang is postdoctoral research fellow of Institute of Pharmacology at National Yang Ming University.

Ting-Ting received her Ph. D. in Department and Institute of Pharmacology from National Yang Ming University.

Legal Adviser, Michael Wong, PhD

Public Relations Consultant, Zhao-Ping Chen　

PricewaterhouseCoopers Taiwan　 Financial Advisor

One of the Big Four Firms in the world